Bright Minds Biosciences (DRUG) Short Interest Ratio & Short Volume $27.55 +0.09 (+0.33%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bright Minds Biosciences Short Interest DataBright Minds Biosciences (DRUG) has a short interest of 80,300 shares, representing 1.63% of the float (the number of shares available for trading by the public). This marks a -7.49% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 825,226 shares to cover all short positions.Current Short Interest80,300 sharesPrevious Short Interest86,800 sharesChange Vs. Previous Month-7.49%Dollar Volume Sold Short$2.60 millionShort Interest Ratio2.3 Days to CoverLast Record DateMay 15, 2025Outstanding Shares7,044,000 sharesFloat Size4,930,000 sharesShort Percent of Float1.63%Today's Trading Volume10,568 sharesAverage Trading Volume825,226 sharesToday's Volume Vs. Average1% Short Selling Bright Minds Biosciences? Sign up to receive the latest short interest report for Bright Minds Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDRUG Short Interest Over TimeDRUG Days to Cover Over TimeDRUG Percentage of Float Shorted Over Time Bright Minds Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202580,300 shares $2.60 million -7.5%1.6%2.3 $32.36 4/30/202586,800 shares $2.66 million -0.1%1.8%2.2 $30.70 4/15/202586,900 shares $2.82 million -12.8%1.8%1.7 $32.41 3/31/202599,700 shares $3.60 million -8.2%2.0%1.6 $36.07 3/15/2025108,600 shares $3.89 million +0.8%2.2%1.6 $35.78 2/28/2025107,700 shares $4.01 million -14.8%2.2%1.4 $37.24 2/15/2025126,400 shares $5.28 million -8.2%2.6%1.2 $41.80 1/31/2025137,700 shares $4.68 million -19.9%2.7%1 $34.00 1/15/2025172,000 shares $6.18 million -2.7%3.4%0.6 $35.92 12/31/2024176,700 shares $6.36 million -20.1%3.5%0.1 $36.02 Get the Latest News and Ratings for DRUG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bright Minds Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/15/2024221,200 shares $9.07 million -0.1%4.4%0.1 $41.00 11/30/2024221,400 shares $9.74 million -16.4%4.4%0.1 $44.00 11/15/2024264,800 shares $10.49 million -17.9%5.2%0.1 $39.61 10/31/2024322,600 shares $15.10 million -72.4%11.7%0.1 $46.80 10/15/20241,170,000 shares $45.03 million +1,274.9%38.2%0.4 $38.49 9/30/202485,100 shares $99,567.00 -19.6%3.0%0.8 $1.17 9/15/2024105,900 shares $135,022.50 -41.7%3.7%1 $1.28 8/31/2024181,500 shares $192,390.00 +149.7%6.3%1.8 $1.06 8/15/202472,700 shares $74,881.00 +0.6%2.5%0.8 $1.03 7/31/202472,300 shares $83,868.00 +3.6%2.5%3.4 $1.16 7/15/202469,800 shares $71,196.00 -2.0%2.4%3 $1.02 6/30/202471,200 shares $77,223.52 -0.4%2.5%6 $1.08 6/15/202471,500 shares $75,075.00 -13.5%2.5%4.5 $1.05 5/31/202482,700 shares $100,067.00 +17.5%2.9%4.4 $1.21 5/15/202470,400 shares $76,384.00 No Change2.5%3.6 $1.09 4/30/202470,400 shares $70,400.00 -7.0%2.6%3.3 $1.00 4/15/202475,700 shares $93,111.00 +7.2%2.8%3.1 $1.23 3/31/202470,600 shares $84,712.94 -3.6%2.6%2.5 $1.20 3/15/202473,200 shares $95,160.00 +3.1%2.7%2.2 $1.30 2/29/202471,000 shares $127,800.00 +0.3%2.6%2 $1.80 2/15/202470,800 shares $138,760.92 -0.4%2.5%1.9 $1.96 1/31/202471,100 shares $151,443.00 -9.1%2.9%2 $2.13 1/15/202478,200 shares $151,012.02 +7.6%3.2%2.6 $1.93 12/31/202372,700 shares $103,961.00 -5.6%3.0%2.4 $1.43 12/15/202377,000 shares $115,500.00 -9.4%3.0%3.3 $1.50 11/30/202385,000 shares $113,900.00 +21.6%3.3%3.6 $1.34 11/15/202369,900 shares $88,773.00 -1.4%2.7%2.3 $1.27 10/31/202370,900 shares $95,715.00 -1.3%2.7%1.1 $1.35 10/15/202371,800 shares $112,008.00 -1.0%2.8%0.1 $1.56 9/30/202372,500 shares $116,000.00 -1.0%2.8%0.1 $1.60An AI run of epic proportions is only getting started (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 9/15/202373,200 shares $114,924.00 -12.8%2.8%0.1 $1.57 8/31/202383,900 shares $180,385.00 -50.7%3.2%0.1 $2.15 8/15/2023170,200 shares $451,030.00 +49.3%6.6%0.3 $2.65 7/31/2023114,000 shares $474,240.00 +16.9%4.4%0.2 $4.16 7/15/202397,500 shares $358,800.00 -80.7%3.8%0.9 $3.68 6/30/2023505,400 shares $1.44 million -7.5%3.8%0.7 $2.85 6/15/2023546,300 shares $319,694.76 -19.8%4.1%0.8 $0.59 5/31/2023680,900 shares $427,060.48 +15.9%4.8%1 $0.63 5/15/2023587,600 shares $317,304.00 -13.0%4.1%0.9 $0.54 4/30/2023675,000 shares $424,372.50 +38.2%4.7%1 $0.63 4/15/2023488,600 shares $200,277.14 +2.2%3.4%0.7 $0.41 3/31/2023478,100 shares $210,411.81 -0.1%3.4%3.7 $0.44 3/15/2023478,500 shares $229,680.00 +0.8%3.4%2.8 $0.48 2/28/2023474,800 shares $273,603.50 -22.4%3.3%2.5 $0.58 2/15/2023612,100 shares $448,669.30 +4.3%4.4%2.8 $0.73 1/31/2023586,900 shares $422,157.17 +11.6%4.2%2.2 $0.72 1/15/2023525,700 shares $415,303.00 -21.8%3.8%1.9 $0.79 12/30/2022672,200 shares $497,428.00 -17.9%4.9%1.1 $0.74 12/15/2022818,500 shares $746,881.25 -0.8%8.3%1.2 $0.91 11/30/2022824,900 shares $899,141.00 -11.6%11.0%0.6 $1.09 11/15/2022932,900 shares $918,906.50 +23.0%12.5%0.1 $0.99 10/31/2022758,600 shares $751,014.00 +58.5%10.1%0.1 $0.99 10/15/2022478,500 shares $435,482.85 +34.6%6.4%0 $0.91 9/30/2022355,600 shares $437,388.00 -24.6%4.9%0 $1.23 9/15/2022471,600 shares $603,648.00 -58.6%6.5%0 $1.28 8/31/20221,140,000 shares $2.19 million +1,809.6%16.3%0.1 $1.92 8/15/202259,700 shares $59,538.81 +64.9%0.9%0 $1.00 7/31/202236,200 shares $36,022.62 +10.0%0.5%0.6 $1.00 7/15/202232,900 shares $28,043.93 +56.7%0.5%0.6 $0.85 6/30/202221,000 shares $16,793.70 -56.3%0.3%0.4 $0.80 6/15/202248,100 shares $44,405.92 +2.3%0.7%0.6 $0.92 5/31/202247,000 shares $51,700.00 +144.8%0.7%0.5 $1.10 5/15/202219,200 shares $18,721.92 -28.9%0.3%0.2 $0.98 4/30/202227,000 shares $25,245.00 -26.0%0.4%0.3 $0.94 4/15/202236,500 shares $46,997.40 -21.3%0.6%0.5 $1.29 3/31/202246,400 shares $70,393.44 +29.3%0.7%0.8 $1.52 3/15/202235,900 shares $55,645.00 -29.1%0.6%0.9 $1.55 2/28/202250,600 shares $105,754.00 +13.7%0.8%3.6 $2.09 2/15/202244,500 shares $107,690.00 -11.9%0.7%2.2 $2.42 1/31/202250,500 shares $122,715.00 +6.3%0.7%0.3 $2.43 1/15/202247,500 shares $135,850.00 +43.5%0.7%0.3 $2.86 12/31/202133,100 shares $104,927.00 No Change0.5%0.2 $3.17 DRUG Short Interest - Frequently Asked Questions What is Bright Minds Biosciences' current short interest? Short interest is the volume of Bright Minds Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 80,300 shares of DRUG short. 1.63% of Bright Minds Biosciences' shares are currently sold short. Learn More on Bright Minds Biosciences' current short interest. What is a good short interest ratio for Bright Minds Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DRUG shares currently have a short interest ratio of 2.0. Learn More on Bright Minds Biosciences's short interest ratio. What is a good short interest percentage for Bright Minds Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.63% of Bright Minds Biosciences' floating shares are currently sold short. Is Bright Minds Biosciences' short interest increasing or decreasing? Bright Minds Biosciences saw a drop in short interest in May. As of May 15th, there was short interest totaling 80,300 shares, a drop of 7.5% from the previous total of 86,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bright Minds Biosciences' float size? Bright Minds Biosciences currently has issued a total of 7,044,000 shares. Some of Bright Minds Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bright Minds Biosciences currently has a public float of 4,930,000 shares. How does Bright Minds Biosciences' short interest compare to its competitors? 1.63% of Bright Minds Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bright Minds Biosciences: Gyre Therapeutics, Inc. (15.25%), Enliven Therapeutics, Inc. (20.30%), Chimerix, Inc. (4.27%), Avid Bioservices, Inc. (18.17%), LENZ Therapeutics, Inc. (14.33%), Nuvation Bio Inc. (16.68%), Cronos Group Inc. (1.79%), Praxis Precision Medicines, Inc. (10.34%), Xeris Biopharma Holdings, Inc. (12.51%), Akebia Therapeutics, Inc. (9.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Bright Minds Biosciences stock? Short selling DRUG is an investing strategy that aims to generate trading profit from Bright Minds Biosciences as its price is falling. DRUG shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bright Minds Biosciences? A short squeeze for Bright Minds Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DRUG, which in turn drives the price of the stock up even further. How often is Bright Minds Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DRUG, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies GYRE Short Interest ELVN Short Interest CMRX Short Interest CDMO Short Interest LENZ Short Interest NUVB Short Interest CRON Short Interest PRAX Short Interest XERS Short Interest AKBA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DRUG) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump plotting new lockdown?It's listed inside the White House's own documents: Federal Register notice 90 FR 4544 to be exact. And wh...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DRUG Stock Free DRUG Stock Alerts